Drug · DIN 02475898
AG-EZETIMIBE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since July 20, 2018; first marketed July 20, 2018.
- Drug Identification Number (DIN)
- 02475898
- Company (DIN owner)
- Angita Pharma Inc.Boucherville, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Ezetimibe C10AX09
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| EZETIMIBE | 10 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 29, 2018: NOC 20909Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies